Healthy subjects ( mean age @ yrs ) and patients with COPD ( mean age @ yrs , mean post-bronchodilator FEV@ @ % predicted normal value ) were randomised @:@ to active treatment ( @ , @ or @ g delivered doses of AZD@ ) or placebo .